Assessment of plasma p ‐tau217 performance: diagnostic accuracy and pathology discrimination

Abstract

Background: Our objectives were to determine the diagnostic accuracy of plasma p ‐tau217 and its discriminative power for the Alzheimer's disease‐related pathology, and to determine the cut‐off that optimize the concordance with Aβ42/Aβ40 positive vs negative status.

The paper